Topics

Pioneering red light-activated anti-tumor prodrug reduces side effects

09:19 EDT 2 Oct 2019 | Science Daily

Phorbiplatin is a new anti-cancer prodrug that can be controllably activated by red light. With its unique 'on-site' activation characteristic, this new prodrug can effectively kill cancer cells and minimize damage to normal tissues.

Original Article: Pioneering red light-activated anti-tumor prodrug reduces side effects

NEXT ARTICLE

More From BioPortfolio on "Pioneering red light-activated anti-tumor prodrug reduces side effects"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...